Trial Profile
F 18 T807 Tau PET Imaging of Alzheimer's Disease [IND 123119] Protocol A
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 May 2023
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Diagnostic use
- 02 Sep 2021 Status changed from active, no longer recruiting to recruiting.
- 01 Oct 2020 Planned number of patients increased from 100 to 900.
- 01 Oct 2020 Planned number of patients changed from 100 to 900.